NEW YORK (GenomeWeb) – The US Patent and Trademark Office's Patent Trial and Appeal Board has invalidated a number of claims in a patent held by RainDance Technologies following an inter partes review of an intellectual property dispute between RainDance and 10x Genomics.

10x Genomics requested an inter partes review, which was granted last January, of RainDance's US Patent No. 8,658,430 B2, which concerns methods and systems for manipulating droplet size.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.